|Articles|July 1, 2007

Pharmacy Times

  • Volume 0
  • 0

Update on Investigational Alzheimer's Drug

Author(s)Susan Farley

Voyager Pharmaceutical Corp recently informed its shareholders of preliminary results from a trial of an investigational drug to treat Alzheimer's disease (AD). The researchers studying the drug, Memryte, observed positive effects among women but not among men.

The findings have prompted Voyager to focus on developing the drug to treat AD specifically for women.

Articles in this issue

over 18 years ago

pharmacy TECHNOLOGY news

over 18 years ago

pharmacy TECHNOLOGY products

over 18 years ago

health-systems PRODUCT news

over 18 years ago

generic times product news

over 18 years ago

can you READ these Rxs?

over 18 years ago

A closer look at new FDA actions

over 18 years ago

can you READ these Rxs?

over 18 years ago

compounding HOTLINE

over 18 years ago

Is There Science in Quality?

over 18 years ago

Vaccines: Are You Protected?

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME